Former CFO of Alantos; Principal at Earlybird until moving to Alantos

“As a chemist and molecular biologist, I recognized the outstanding potential from the start and wanted to play an even more active role part in the company’s development, above providing normal support. That is why I decided to join Alantos, and work as CFO to drive the business forward. I stayed with the company for over four years until its successful sale. Earlybird supported us particularly when it came to the systematic commercial direction of the company, making the leap to the United States, and searching for a suitable CEO.”

At the time of Earlybird’s investment in Alantos, Jaffé had been a Principal at Earlybird. Alantos had already developed the basic technology and was heading towards commercialization. His step to Alantos and his commitment proved to be rewarding for both Jaffé and Earlybird: Alantos was sold to Amgen for US$ 300 million.